Literature DB >> 21514636

Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies.

Nima Rezaei1, Mona Hedayat, Asghar Aghamohammadi, Kim E Nichols.   

Abstract

Primary immunodeficiencies (PIDs) are commonly characterized by an increased susceptibility to specific infections and, in certain instances, a higher than usual incidence of malignancies. Although improved diagnosis and early treatment of PIDs have reduced early morbidity and mortality from infection, the development of cancer remains a significant cause of premature death. The emergence of cancer in patients with PIDs often results from impairments in the immune response that lead to weakened surveillance against oncogenic viruses, premalignant or malignant cells, or both. Here we review the clinical and biologic features of several PIDs associated with enhanced susceptibility to viral infections and cancer, including X-linked lymphoproliferative disease; IL-2-inducible T-cell kinase deficiency; epidermodysplasia verruciformis; warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; autosomal recessive hyper-IgE syndrome; X-linked agammaglobulinemia; and common variable immunodeficiency. It is of importance that we gain in-depth insights into the fundamental molecular nature of these unique PIDs to better understand the pathogenesis of virus-associated malignancies and to develop innovative therapeutic strategies.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514636     DOI: 10.1016/j.jaci.2011.02.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  43 in total

1.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry.

Authors:  Asghar Aghamohammadi; Payam Mohammadinejad; Hassan Abolhassani; Babak Mirminachi; Masoud Movahedi; Mohammad Gharagozlou; Nima Parvaneh; Vaheid Zeiaee; Bahram Mirsaeed-Ghazi; Zahra Chavoushzadeh; Alireza Mahdaviani; Mahboubeh Mansouri; Sedigheh Yousefzadegan; Bahareh Sharifi; Fariborz Zandieh; Ehsan Hedayat; Ali Nadjafi; Roya Sherkat; Behzad Shakerian; Mahnaz Sadeghi-Shabestari; Reza Farid Hosseini; Farahzad Jabbari-Azad; Hamid Ahanchian; Fatemeh Behmanesh; Mohammadreza Zandkarimi; Afshin Shirkani; Taher Cheraghi; Abbas Fayezi; Iraj Mohammadzadeh; Reza Amin; Soheila Aleyasin; Mojgan Moghtaderi; Javad Ghaffari; Saba Arshi; Naser Javahertrash; Mohammad Nabavi; Mohammad Hassan Bemanian; Alireza Shafiei; Najmedin Kalantari; Akefeh Ahmadiafshar; Hossein Ali Khazaei; Lida Atarod; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05       Impact factor: 8.317

3.  Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.

Authors:  Alexandra Nieters; Anna Łuczyńska; Susen Becker; Nikolaus Becker; Roel Vermeulen; Kim Overvad; Krasimira Aleksandrova; Heiner Boeing; Pagona Lagiou; Dimitrios Trichopoulos; Antonia Trichopoulou; Vittorio Krogh; Giovanna Masala; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Bas Bueno-de-Mesquita; Suzanne M Jeurnink; Elisabete Weiderpass; Eva Ardanaz; Maria-Dolores Chirlaque; María-José Sánchez; Soledad Sánchez; Signe Borgquist; Salma Butt; Beatrice Melin; Florentin Späth; Sabina Rinaldi; Paul Brennan; Rachel S Kelly; Elio Riboli; Paolo Vineis; Rudolf Kaaks
Journal:  Carcinogenesis       Date:  2014-09-30       Impact factor: 4.944

Review 4.  Genetics on a WHIM.

Authors:  Omar Al Ustwani; Razelle Kurzrock; Meir Wetzler
Journal:  Br J Haematol       Date:  2013-09-20       Impact factor: 6.998

Review 5.  XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Helen Su; Gulbu Uzel; Helen Matthews; Michael J Lenardo
Journal:  Blood       Date:  2014-02-18       Impact factor: 22.113

6.  Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model.

Authors:  David W Kang; Laurence Jadin; Tara Nekoroski; Fred H Drake; Monica L Zepeda
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

7.  Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar.

Authors:  Mohammad S Ehlayel; Abdulbari Bener; Mohammad Abu Laban
Journal:  J Clin Immunol       Date:  2012-10-03       Impact factor: 8.317

Review 8.  Advances in basic and clinical immunology in 2011.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

9.  Behavior of circulating CD4+CD25+Foxp3+ regulatory T cells in colon cancer patients undergoing surgery.

Authors:  Ausilia Sellitto; Gennaro Galizia; Umberto De Fanis; Eva Lieto; Anna Zamboli; Michele Orditura; Ferdinando De Vita; Riccardo Giunta; Giacomo Lucivero; Ciro Romano
Journal:  J Clin Immunol       Date:  2011-09-14       Impact factor: 8.317

10.  Epidemiology of Primary Immunodeficiency in Iceland.

Authors:  Bjorn R Ludviksson; Sigurveig T Sigurdardottir; Johann Heidar Johannsson; Asgeir Haraldsson; Thorgeir O Hardarson
Journal:  J Clin Immunol       Date:  2014-10-15       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.